March 6, 2018 / 9:17 PM / 7 months ago

BRIEF-Rigel Pharma Q4 Loss Per Share $0.18

March 6 (Reuters) - Rigel Pharmaceuticals Inc:

* RIGEL ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

* Q4 LOSS PER SHARE $0.18

* ‍THERE WERE NO CONTRACT REVENUES FROM COLLABORATIONS IN Q4 OF 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below